BRAINSTORM CELL THERAPEUTICS INC. cotiza a 0.83 USD y tiene una capitalización bursátil de $9M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-deriv…
| Periodo | 2026-05 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | $-0.19 | — | $-0.13 | $-0.19 |
| Estimado | $-0.36 | $-0.36 | $-0.43 | $-0.37 |
| Sorpresa | +47.2% | — | +69.8% | +48.6% |
| Métrica | BCLI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -1008.5% | -32.0% | -976.5% |
| Current Ratio | 0.03 | 2.84 | -2.81 |
| Debt / Equity | — | 0.28 | — |